BAUSCH FDA Approval NDA 050584

NDA 050584

BAUSCH

FDA Drug Application

Application #050584

Application Sponsors

NDA 050584BAUSCH

Marketing Status

Discontinued001

Application Products

001OINTMENT;TOPICAL2%1AKNE-MYCINERYTHROMYCIN

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1985-01-10STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1995-07-14STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1995-07-14STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1997-09-22STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL5AP2001-02-28STANDARD

Submissions Property Types

SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0

CDER Filings

BAUSCH
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 50584
            [companyName] => BAUSCH
            [docInserts] => ["",""]
            [products] => [{"drugName":"AKNE-MYCIN","activeIngredients":"ERYTHROMYCIN","strength":"2%","dosageForm":"OINTMENT;TOPICAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"AKNE-MYCIN","submission":"ERYTHROMYCIN","actionType":"2%","submissionClassification":"OINTMENT;TOPICAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.